CVS said there is currently a two-product limit on all children's pain-relief products at all its pharmacy locations and online, while Walgreens said it had put a limit of six over-the-counter pediatric fever reducers per online transaction
The proposed settlement calls for CVS to pay $5 billion over 10 years, Walgreens to pay $5.7 billion over 15 years and Walmart to pay $3.1 billion, mostly up front, according to the people.
The deal, announced last month, was expected to face a tough antitrust review even though the two companies do not compete directly in any market, according to experts.
Walmart Healthcare Research Institute, the largest U.S. retailer's new healthcare research service, will find participants for clinical trials, and Walmart also host MyHealthJourney, a patient portal that helps people find upcoming research trials and track their care.
The District of Columbia Court of Appeals recently reversed lower-court rulings against the nonprofit Center for Inquiry (CFI), which alleged that CVS Pharmacy and Walmart are violating Washington, D.C.'s Consumer Protection Procedures Act by implying that homoeopathic remedies and scientifically proven medicine are equally effective alternatives.
High and rising healthcare prices, which have put even older drugs like insulin out of the reach of poorer people, have bedeviled U.S. presidential administrations determined to slow the rising costs.
CVS said Signify has more than 10,000 employees including physicians and nurses, a presence in every state, and offers technology platforms.
Cerebral and Done are known for treating patients with ADHD, prescribing stimulants such as Adderall.
The $69 billion deal is being reviewed by the U.S. Department of Justice and if approved it would be the second largest healthcare deal this year - one that the companies say will help cut soaring costs in the sector.
The AMA said that the $69 billion deal, announced in December, would lead to a "substantial reduction" of competition in pharmacy benefit (PBM) services market and the Medicare Part D prescription drug plan for seniors.
The deal closure, that involved approvals from the US regulatory agencies, will see Cipla vault its sales from that market to around $400 million.
Get updates on your preferred social platform
Follow us for the latest news, insider access to events and more.
